{'text': 'Sanofi gets US approval for use of Priftin drug in latent TB', 'publisher': {'href': 'https://www.reuters.com', 'title': 'Reuters'}, 'created_at': 'Mon, 01 Dec 2014 08:00:00 GMT', 'description': 'Sanofi gets US approval for use of Priftin drug in latent TB  Reuters', 'url': 'https://news.google.com/rss/articles/CBMi2wFBVV95cUxOS3NwVUFIS0FzN09JbkV6NzVnbUdjYXU4b0JUdVdrWDQxQ1JUc21rZ04zYl9EcU1GbnBuV3lNNlhpc0tCVm1HR3JDem1NUDZRdHN4bVlvWUpleGc4dTlNNzAtODJhaUJpV0h4MjJvRGpobE5aRkFCbUdqRHFLYUhReXNYVS1FVDQ2dWxPamJhOXJFbDNoQ1NTS2hhQUN6ZXhqeVplUDRWd1pDZ3NaQkMtaHl5THRUaElnQXcxX29ZSmQtVXR3UlYxUWtMTzhxbUFKMXhaUmo2MjUwQ0U?oc=5&hl=en-US&gl=US&ceid=US:en'}
{'text': 'Sanofi gets U.S. approval for use of Priftin drug in latent TB', 'publisher': {'href': 'https://www.reuters.com', 'title': 'Reuters'}, 'created_at': 'Mon, 01 Dec 2014 08:00:00 GMT', 'description': 'Sanofi gets U.S. approval for use of Priftin drug in latent TB  Reuters', 'url': 'https://news.google.com/rss/articles/CBMi2wFBVV95cUxOVUcySmVQd1BING5DeV91eVlIazlwdE45RVNJOVE0dUtrMHlHdXlUMEpNVGhlRV9Oei1VWHRGUjRlM3VMeTR2Mnh0TWw3dWVDZzNuaFN3S2RIVnJfcDM5WDliazZ0bjBrVkc4RWJMQWRtN3ZJckRjS19WTU1yS1dhNENRWTdZanpCaTQ3cldjem03RXhvVGdna242QnktVUNCM2ZxM0hsNFF6Xy1fN19vZkNKbW1zRzZxWU43QVNOdEEzWFRrQnd6aVRURkYyT0xFTHZLcDdodlFlZ1E?oc=5&hl=en-US&gl=US&ceid=US:en'}
